BLU-945
BLU-945 is a selective, oral EGFR tyrosine kinase inhibitor designed to target resistant mutations like L858R/T790M/C797S. It is a research tool for studying non-small cell lung cancer (NSCLC), demonstrating activity in both in vitro cell line models and in vivo studies.
Product Specifications
CAS Number
2660250-10-0
Product Name Alternative
EGFR, BLU945, BLU-945, BLU 945
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.11% (May vary between batches)
Solubility
DMSO:250 mg/mL (449.07 mM)
Smiles
CO[C@@H]1CCN (C[C@@H]1F) c1nccc (Nc2cc3c (ccc (N4C[C@H] (CS (C) (=O) =O) [C@H]4C) c3cn2) C (C) C) n1
Molecular Formula
C28H37FN6O3S
Molecular Weight
556.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6458468-01 0.1 mL
PRSS21 (Testisin, 3421-, Eosinophil Serine Protease 1, ESP-1, Serine Protease 21, PRSS21, ESP1, TEST1) (MaxLight 550)
Sign In for Pricing
View Details MBS6458468-02 5x 0.1 mL
PRSS21 (Testisin, 3421-, Eosinophil Serine Protease 1, ESP-1, Serine Protease 21, PRSS21, ESP1, TEST1) (MaxLight 550)
Sign In for Pricing
View Details 
bsm-61673R-FITC-01 20 µL
PAK2 Recombinant Antibody, FITC Conjugated
Sign In for Pricing
View Details bsm-61673R-FITC-02 100 µL
PAK2 Recombinant Antibody, FITC Conjugated
Sign In for Pricing
View Details